TrialCMAJ open

Cost-effectiveness of remdesivir plus usual care versus usual care alone for hospitalized patients with COVID-19: an economic evaluation as part of the Canadian Treatments for COVID-19 (CATCO) randomized clinical trial.

Vincent I Lau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.